SMOLDERING PLASMA CELL MYELOMA
Clinical trials for SMOLDERING PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new SMOLDERING PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for SMOLDERING PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to stop 'Smoldering' cancer in its tracks
Disease control Recruiting nowThis study is testing whether a new immunotherapy drug called iberdomide can delay or prevent a pre-cancerous blood condition from turning into active multiple myeloma. It will involve about 68 adults with intermediate or high-risk smoldering myeloma. Patients will receive iberdo…
Matched conditions: SMOLDERING PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Major trial aims to stop Pre-Cancer in its tracks
Disease control Recruiting nowThis study is for people diagnosed with high-risk smoldering myeloma, a condition where abnormal blood cells are present but haven't yet caused active cancer symptoms. The goal is to see if adding a newer immunotherapy drug (daratumumab) to a standard two-drug treatment (lenalido…
Matched conditions: SMOLDERING PLASMA CELL MYELOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Can exercise, fasting, or a common pill boost cancer Patients' health?
Symptom relief Recruiting nowThis study is testing whether non-drug approaches like exercise, intermittent fasting, and adding a common blood pressure medication (propranolol) to standard treatment can improve the immune system and quality of life for people with multiple myeloma or related blood disorders. …
Matched conditions: SMOLDERING PLASMA CELL MYELOMA
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Mar 02, 2026 15:23 UTC
-
Tracking the path to myeloma: can we predict cancer before it strikes?
Knowledge-focused Recruiting nowThis study aims to understand why some people with early, symptom-free blood cell conditions (MGUS or smoldering myeloma) develop full multiple myeloma while others don't. Researchers will follow 200 patients for 3 years, collecting blood samples and tracking their health to iden…
Matched conditions: SMOLDERING PLASMA CELL MYELOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Listening to the silent struggle: study probes hidden worries of patients with early blood disorders
Knowledge-focused Recruiting nowThis study aims to understand the quality of life and anxiety experienced by patients with early-stage blood conditions called MGUS and smoldering myeloma. It involves 400 patients who are already in other related studies at MD Anderson. Participants will fill out questionnaires …
Matched conditions: SMOLDERING PLASMA CELL MYELOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC